Breaking: A federal judge on Monday stalled major parts of health secretary Robert F. Kennedy Jr.’s campaign to remake ...
A full-year subscription to STAT is currently half off — half off! Your journalistic conscience will be full. Sounds like a ...
Asthma patients suffered as GSK pursued ‘egregious’ price hikes and monopolized market, senator says
After GSK replaced a popular asthma inhaler with an identical product at a higher price, families reported substantial financial and treatment problems, according to a new report.
Two people with paralysis were able to type using a brain-computer interface that decodes attempted finger movement, a new study showed.
Medicare delays stall breakthrough device access, ALS carriers fear research setbacks under Trump, and more biotech news ...
Structure Therapeutics disclosed that its daily obesity pill led patients to lose about 16% of their body weight relative to placebo after 44 weeks ...
After permission to work from home was temporarily revoked in September, disabled CDC workers are still struggling to get needed accommodations, according to a letter sent to NIH Director and acting ...
An experimental obesity pill from Structure Therapeutics helped patients lose significant weight in a mid-stage trial, with a Phase 3 study in the works.
"Watching my mom die of ALS was one of the most awful things I’ve gone through. I don’t want my children to see me suffer like that." ...
Congress must pass bipartisan legislation to ensure Medicare coverage of breakthrough medical technologies, writes a physician and inventor.
Perfusion technology vastly improves organ quality in transplants, but high costs and coverage questions pose barriers in becoming the standard of care.
Submit a response to a recent First Opinion essay below. Selected submissions will appear in our weekly letter to the editor roundup, published every Saturday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results